Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

Wu Y, Xu Z, Zhang K, Wu J, Li X, Arshad B, Li Y, Wang Z, Li H, Wu K, Kong L

Therapeutics and Clinical Risk Management 2018, 14:1789-1797

Published Date: 26 September 2018